10 / 40
Israel-India Business Guide - MedTech, Pharma & Biotech
10
MedTech
Facts & Figures
Innovation, Ingenuity and
Creativity
With around 1,000 Life Science companies and 40 new companies being
formed each year, Israel's Life Science industry has become one of the
leading Life Science Industries in the world
I
srael'sthrivinglifesciencesindustryisworld-renownedfor
its groundbreaking innovations, ingenuity and creativity.
It is home to around 1,000 life science companies, with
40 new companies being formed each year. Multinational
companies including J&J, Perrigo, GE Healthcare and Phillips
Medical, together with local companies such as Teva,
Insightec, Medinol, Compugen, Kamada and others have
been at the forefront in the development and marketing of
life-changingmedical devices, treatments andmedications.
Fast Facts
• First in the world in the quality of scientific research
institutions (WEF 2013-14).
• First in the world for the number of medical device
patents per capita; fourth for biopharma patents (US
Patents and Trademarks Office 2009).
• Second in Europe in per capita of private biotech
companies’ products in pipeline.
• One of the leading publishers of stem cell research in the
world.
Breakthrough Medical Devices and
Biopharmaceuticals
Israel’s breakthroughs are often a result of several
converging technologies including physics, mathematics,
computer sciences, nanotechnology and others.
• Pillcam, the first miniature ingested camera which
diagnoses and photographs abnormalities in the
gastrointestinal tract was introduced by
Given Imaging
,
acquired in 2014 by Ireland’s Covidien.
• Galil Medical
’s minimally invasive cryotherapy solutions
freeze and ablate benign cancerous tissue, thereby
hastening a patient’s’ recovery.
• Teva
’s Copaxone for the treatment of Multiple Sclerosis
and Azilect for Parkinson’s disease are revolutionary
drugs developed in Israel.
• Medinol
’s closed cell stent is used worldwide for heart
catheterization.
• Rebif
, a treatment for Central Nervous System disorders
was developed by the Weizmann Institute and Serono.
• Insightec
developed the ExAblate 2000 non-invasive
surgery, which uses MR guided focused ultrasound to
treat uterine fibroids. (Pictured: ExAblate procedure
courtesy of Insightec)
• Exelon, a drug for the treatment of Alzheimer’s originated
at the Hebrew University and was developed and
marketed by Novartis.
• A chemotherapy drug for the treatment of ovarian
cancer, Doxil, was developed at the Hadassah Medical
Center and sold to Johnson & Johnson.
• Microneedle based systems for the painless intradermal
deliveryof drugswas implementedby
NanoPass,
which
collaborated with GlaxoSmithKline on optimization of its
platform for vaccine delivery.
Cutting-Edge R&D by Emerging Companies
• The NovoTTF, a portable, wearable device that delivers
an anti-mitotic, anti-cancer therapy as patients maintain
their normal activities, was developed by
Novocure
.
• Ventor
, acquired by Medtronic in 2009, created a
unique aortic valve prosthesis which can be implanted
“off pump”, on a beating heart.
• The
superDimension
i-Logic System, acquired by
Covidien in 2012, uses Electromagnetic Navigation
Bronchoscopy (ENB) to provide minimally invasive
access to lesions deep in the lungs as well as mediastinal
lymph nodes, enabling physicians to diagnose benign
and malignant lung lesions and avoid the need for
higher-risk procedures.
• Kamada
’s D1-AAT drug with AAT (Alpha-1 antitrypsin)
protein, which treats Type 1 diabetes, is a breakthrough
treatment of the disease, which may greatly reduce the
body’s need for insulin.
• Vaxil
’s lead therapeutic vaccine ImMucin is a novel
treatment for various forms of cancer.
International Awards
• Lunguard
, an unique disposable PFT (Peristaltic Feeding
Tube), that is monitored and controlled 24/7 by the
bedside CMU, was cited as part of 2011 Red Herring’s
Top 100 Europe list.
• Neurosonix
received the EuropeanAssociation of Cardiac-
Thoracic Surgery Techno-College Innovation Award for its
EmBlocker, which uses ultrasonic energy to non-invasively
divert emboli flow away from the cerebral arteries.
• EarlySense
, developer of the EverOnpatient supervision
system for post-acute care was the winner of a 2010
Popular Science Best of What’s New award.
Source: Invest in Israel